Relationship between cyclooxygenase 2 and angiogenesis diseases and regulation of angiogenesis by cyclooxygenase 2
Hui-feng Zhu,Dong Wan,Fa-jin Lü,Xiao-yu Xu
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.45.058
2006-01-01
Abstract:Objective: The cyclooxygenase-2 (COX-2) is closely correlated with the angiogenesis disease of tumor, the inhibitor of which can inhibit angiogenesis. In this article, the development in research on COX-2 and angiogenesis was reviewed. Data Sources: A computer-based search was conducted in Pubmed for relevant articles published between May 1999 and December 2005 with the key words of "cyclooxygenase-2, COX-2", and the language was limited to English. Meanwhile, relevant Chinese articles between December 1977 and December 2005 were searched in Wanfang database with the key words of "cyclooxygenase-2, angiogenesis". Study Selection: Data were checked in the first trial, and the quotations at the end of each articles were looked for. Inclusion criteria: Articles related to COX-2, inhibitor of COX-2 and angiogenesis. Exclusion criteria: repetitive studies or Meta analytical studies. Data Extraction: Totally 423 relevant literatures were collected, and 16 studies were in accordance with the inclusion criteria. 407 old and repetitive literatures were excluded. Of 16 enrolled articles, 16 ones were involved in the COX system, 8 ones related to COX-2 and angiogenesis, 8 ones were about the mechanism and signal bypass of COX-2 in the, regulation of angiogenesis and 2 literatures on the prospect of COX-2. Data Synthesis: As a multifunctional inflammation modulator, COX-2 has been related tightly with neurodegenerative diseases, such as inflammation, ulceration, stroke and so on. Recent studies show that COX-2 is a new gene in regulating the expression of vascular endothelial growth factor, whose downstream product PG12 is closely correlated with endothelial contraction and platelet aggregation, and COX-2-derived prostaglandin E2 regulates the angiogenesis. The cardiovascular side-effect of COX-2 significantly manifests that it is important to reevaluate the COX-2. Conclusion: COX-2 and its inhibitor not only relate with imflammatory diseases, but also closely correlate with angiogenesis diseases. New therapeutic strategies target-mediated-damage in the downstream of COX-2 offer great promise.